LinkZill will be exhibiting at SynBioBeta 2026 in San Jose

2026-04-30

Just next week, LinkZill will be exhibiting at SynBioBeta 2026 in San Jose, connecting with the global synthetic biology community.
Visit us at Booth #306 from May 4–7 to see our oligonucleotide microarray synthesizer, and learn about our unique TFT semiconductor-based DNA synthesis technology.
A key highlight: Dr. Bingyin (Brian) Wang, Director of the Life Sciences Business Unit at LinkZill, will unveil our Oligo Microarray Synthesizer for the first time in the United States.
He will also host the panel “Closing the Loop at 10ⁿ Scale: The Autonomous DBTL Stack,” joined by Michael Chen of Nuclera and Sharroll Bachas of Onava, to discuss how autonomous DBTL systems can enable software-like iteration in biology and reshape programmable discovery.

🗓 4:30 PM-5:15 PM PDT, May 5, 2026
📍 Breakout Room, San Jose Convention Center, CA

In addition, our team will take part in the session “The Democratization of Scale: From Billion-Dollar Facilities to Desktop Biology,” exploring how lab automation and accessible bioinstrumentation are making experimentation more distributed. Don’t miss it!

🗓 3:30 PM-4:15 PM PDT, May 6, 2026
📍 Breakout Room, San Jose Convention Center, CA
We look forward to seeing you in San Jose!

Dr. Kang Kang

Partner & CBio

Dr. Kang received his Ph.D. in Bioinformatics and Systems Biology from the University of Hong Kong in 2018, then became a scientific co-worker of the Leibniz Association (Leibniz-HKI) and a visiting scientist at the Novo Nordisk Foundation Center for Biosustainability (DTU Biosustain) at the Technical University of Denmark. He was a scientist at BGI-Shenzhen and co-founded the synthetic biology research group. He was a senior bioinformatics engineer and brand advisor at WeGene. In 2021, Kang joined Biosysen Limited as a co-founder and served as Chief Informatics Scientist. He is also an advisor and author of the biotech media "Regenesis". He has been dedicated to the R&D and industrialization of OMICs technologies, high-throughput technologies, and synthetic biology for over 10 years. He joined LinkZill in March 2023, responsible for semiconductor life science tools and product planning.

康康   博士

合伙人兼首席生物信息官

博士毕业于香港大学生物信息和系统生物学专业,后任德国莱布尼茨协会科学合作者、丹麦科技大学诺和诺德生物可持续研究中心访问科学家。曾先后担任华大基因科学家,参与创立了华大基因合成生物学研究方向;微基因资深生物信息工程师、品牌顾问;倍生生物联合创始人兼首席信息科学家。他专注于合成生物学、组学和高通量技术10余年,同时也是生物技术领域颇具影响力的「行业KOL」。2023年3月加入领挚科技,负责半导体生命科学工具方向与产品规划。